AAMRI News

News & Events

Archive

2019+
- June (6)
- May (8)
- April (3)
- March (4)
- February (1)
- January (3)
2018+
- December (2)
- November (7)
- October (8)
- September (2)
- August (4)
- July (7)
- June (4)
- May (7)
- April (1)
- March (4)
- February (2)
- January (3)
2017-
- December (6)
- November (3)
- October (3)
- September (6)
- August (4)
- July (2)
- June (5)
- May (8)
- April (6)
- March (5)
- February (3)
- January (4)
2016+
- December (4)
- November (4)
- October (2)
- September (1)
- August (3)
- July (4)
- June (6)
- May (5)
- April (3)
- March (1)
- February (3)
2015+
- December (2)
- November (3)
- October (3)
- September (3)
- August (3)
- July (1)
- June (2)
- May (6)
- April (2)
- March (3)
- February (6)
- January (2)
2014+
- December (5)
- November (3)
- October (6)
- September (2)
- August (3)
- July (1)
- June (1)
- May (5)
- April (3)
- February (2)
2013+
- October (4)
- September (1)
- August (3)
- July (1)
- June (2)
- May (3)
- April (3)
- March (2)
- February (1)
- January (2)
2012+
- November (2)
- October (2)
- July (1)
- May (3)
- April (2)
- March (2)
- January (1)
2011+

AAMRI > News & Events > AAMRI News

AAMRI News

Landmark $400 million anti-cancer drug royalty deal could be the first of many for Australia
28th July, 2017 · AAMRI News, Media Releases, News & Events
The landmark $400 million deal made by the Walter and Eliza Hall Institute of Medical Research from the partial sale of royalty rights of the anti-cancer drug venetoclax shows the amazing...

Read more
Submission to NHMRC consultation on a framework for assessment and funding of clinical trials and cohort studies
14th July, 2017 · AAMRI News, News & Events, Policy & Advocacy, Submissions
While AAMRI’s submission supports many of the recommendations within the discussion paper, it offers a number of suggestions on improving processes relating to systematic reviews, assessment of...

Read more